[1st clinical experience with a new oral antimycotic in systemic mycoses].
D000273:Adipose Tissue / Q000032:analysis; D000935:Antifungal Agents / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D001228:Aspergillosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D005260:Female; D005499:Folliculitis / Q000188:drug therapy; D006197:Hair / Q000032:analysis; D006801:Humans; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy*; D009262:Nails / Q000032:analysis; D013183:Sputum / Q000032:analysis; D013542:Sweat / Q000032:analysis; D013997:Time Factors
D000935:Antifungal Agents
Erste klinische Erfahrungen bei System-Mykosen mit einem neuen oralen Antimykotikum.